Portfolio company
Centenara Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops and invests in therapeutics targeting age-related diseases for patients needing extended healthspan and improved lifespan.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
Cambrian Biopharma
The company develops therapeutics targeting biological drivers of aging and chronic diseases for pharmaceutical partners, healthcare providers and patients.
Rubedo Life Sciences
This company develops small-molecule therapeutics and anti-ageing skin care products for patients with age-related diseases and consumers seeking skin rejuvenation.
Neotis
This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.
Senisca
This company develops oligonucleotide-based therapeutics that reprogramme senescent cells to treat age-related diseases and aesthetic signs of ageing for patients and pharmaceutical partners.
Rubedo
This biopharmaceutical company develops therapeutics targeting senescent cells to treat chronic age-related diseases for patients with skin and pulmonary conditions.
Cleara Biotech
The company develops peptide-based therapies that target and eliminate senescent cells to treat patients with late-stage cancers and age-related chronic diseases.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
